Site-specific oxidation of flavanone and flavone by cytochrome P450 2A6 in human liver microsomes

References

• Akashi T, Aoki T, Ayabe S. (1998). Identification of a cytochrome P450 cDNA encoding (2S)-flavanone 2-hydroxylase of licorice (Glycyrrhiza echinata L.; Fabaceae) which represents licodione synthase and flavone synthase II. FEBS Lett 431:287–90.
   PubMed Web of Science ®Google Scholar
• Akashi T, Fukuchi-Mizutani M, Aoki T, et al. (1999). Molecular cloning and biochemical characterization of a novel cytochrome P450, flavone synthase II, that catalyzes direct conversion of flavanones to flavones. Plant Cell Physiol 40:1182–6.
   PubMed Web of Science ®Google Scholar
• Arct J, Pytkowska K. (2008). Flavonoids as components of biologically active cosmeceuticals. Clin Dermatol 26:347–57.
   PubMed Web of Science ®Google Scholar
• Bae SH, Kwon MJ, Choi EJ, et al. (2013). Potent inhibition of cytochrome P450 2B6 by sibutramine in human liver microsomes. Chem Biol Interact 205:11–19.
   PubMed Web of Science ®Google Scholar
• Baranowska I, Hejniak J, Magiera S. (2016). Simultaneous chiral separation of flavanone, naringenin, and hesperetin enantiomers by RP-UHPLC-DAD. Chirality 28:147–52.
   PubMed Web of Science ®Google Scholar
• Brand W, Shao J, Hoek-van den Hil EF, et al. (2010). Stereoselective conjugation, transport and bioactivity of S- and R-hesperetin enantiomers in vitro. J Agric Food Chem 58:6119–25.
   PubMed Web of Science ®Google Scholar
• Breinholt VM, Offord EA, Brouwer C, et al. (2002). In vitro investigation of cytochrome P450-mediated metabolism of dietary flavonoids. Food Chem Toxicol 40:609–16.
   PubMed Web of Science ®Google Scholar
• Brown RE, Jarvis KL, Hyland KJ. (1989). Protein measurement using bicinchoninic acid: elimination of interfering substances. Anal Biochem 180:136–9.
   PubMed Web of Science ®Google Scholar
• Chiang HC, Wang CK, Tsou TC. (2012). Differential distribution of CYP2A6 and CYP2A13 in the human respiratory tract. Respiration 84:319–26.
   PubMed Web of Science ®Google Scholar
• Das NP, Scott KN, Duncan JH. (1973). Identification of flavanone metabolites in rat urine by combined gas-liquid chromatography and mass spectrometry. Biochem J 136:903–909.
   PubMed Web of Science ®Google Scholar
• DeVore NM, Meneely KM, Bart AG, et al. (2012). Structural comparison of cytochromes P450 2A6, 2A13, and 2E1 with pilocarpine. FEBS J 279:1621–31.
   PubMed Web of Science ®Google Scholar
• DeVore NM, Scott EE. (2012). Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone binding and access channel in human cytochrome P450 2A6 and 2A13 enzymes. J Biol Chem 287:26576–85.
   PubMed Web of Science ®Google Scholar
• Du Y, Chu H, Chu IK, Lo C. (2010). CYP93G2 is a flavanone 2-hydroxylase required for C-glycosylflavone biosynthesis in rice. Plant Physiol 154:324–33.
   PubMed Web of Science ®Google Scholar
• Fliegmann J, Furtwängler K, Malterer G, et al. (2010). Flavone synthase II (CYP93B16) from soybean (Glycine max L.). Phytochemistry 71:508–14.
   PubMed Web of Science ®Google Scholar
• Fujita K, Kamataki T. (2001). Screening of organosulfur compounds as inhibitors of human CYP2A6. Drug Metab Dispos 29:983–9.
   PubMed Web of Science ®Google Scholar
• Guengerich FP. (2015) Human cytochrome P450 enzymes. In: Ortiz de Montellano PR, ed. Cytochrome P450: structure, mechanism, and biochemistry. 4th ed., pp 523–785. New York: Springer.
   Google Scholar
• Han S, Choi S, Chun YJ, et al. (2012). Functional characterization of allelic variants of polymorphic human cytochrome P450 2A6 (CYP2A6*5, *7, *8, *18, *19, and *35). Biol Pharm Bull 35:394–9.
   PubMed Web of Science ®Google Scholar
• Hodek P, Trefil P, Stiborová M. (2002). Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450. Chem Biol Interact 139:1–21.
   PubMed Web of Science ®Google Scholar
• Hosono H, Kumondai M, Maekawa M, et al. (2017). Functional characterization of 34 CYP2A6 allelic variants by assessment of nicotine C-oxidation and coumarin 7-hydroxylation activities. Drug Metab Dispos 45:279–85.
   PubMed Web of Science ®Google Scholar
• Kagawa H, Takahashi T, Ohta S, Harigaya Y. (2004). Oxidation and rearrangements of flavanones by mammalian cytochrome P450. Xenobiotica 34:797–810.
   PubMed Web of Science ®Google Scholar
• Kakimoto K, Murayama N, Takenaka S, et al. (2018). Cytochrome P450 2A6 and other human P450 enzymes in the oxidation of flavone and flavanone. Xenobiotica, in press: https://doi.org/10.1080/00498254.2018.1426133.
   Web of Science ®Google Scholar
• Kakimoto K, Nagayoshi H, Inazumi N, et al. (2015). Identification and characterization of oxidative metabolites of 1-chloropyrene. Chem Res Toxicol 28:1728–36.
   PubMed Web of Science ®Google Scholar
• Kale A, Gawande S, Kotwal S. (2008). Cancer phytotherapeutics: role for flavonoids at the cellular level. Phytother Res 22:567–77.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Lee S, Park SK, et al. (2005). Effects of hydroxyl group numbers on the B-ring of 5,7-dihydroxyflavones on the differential inhibition of human CYP 1A and CYP1B1 enzymes. Arch Pharm Res 28:1114–21.
   PubMed Web of Science ®Google Scholar
• Kim V, Yeom S, Lee Y, et al. (2018). In vitro functional analysis of human cytochrome P450 2A13 genetic variants: P450 2A13*2, *3, *4, and *10. J Toxicol Environ Health A 81:493–501.
   PubMed Web of Science ®Google Scholar
• Kumondai M, Hosono H, Maekawa M, et al. (2018). Functional characterization of 9 CYP2A13 allelic variants by assessment of nicotine C-oxidation and coumarin 7-hydroxylation. Drug Metab Pharmacokinet 33:82–9.
   PubMed Web of Science ®Google Scholar
• Moon YJ, Wang X, Morris ME. (2006). Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. Toxicol In Vitro 20:187–210.
   PubMed Web of Science ®Google Scholar
• Nikolic D, van Breemen RB. (2004). New metabolic pathways for flavanones catalyzed by rat liver microsomes. Drug Metab Dispos 32:387–97.
   PubMed Web of Science ®Google Scholar
• Omura T, Sato R. (1964). The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 239:2370–8.
   PubMed Web of Science ®Google Scholar
• Parikh A, Gillam EMJ, Guengerich FP. (1997). Drug metabolism by Escherichia coli expressing human cytochromes P450. Nat Biotechnol 15:784–8.
   PubMed Web of Science ®Google Scholar
• Rae JM, Soukhova NV, Flockhart DA, Desta Z. (2002). Triethylenethiophosphoramide is a specific inhibitor of cytochrome P450 2B6: implications for cyclophosphamide metabolism. Drug Metab Dispos 30:525–30.
   PubMed Web of Science ®Google Scholar
• Sandhu P, Baba T, Guengerich FP. (1993). Expression of modified cytochrome P450 2C10 (2C9) in Escherichia coli, purification, and reconstitution of catalytic activity. Arch Biochem Biophys 306:443–50.
   PubMed Web of Science ®Google Scholar
• Sandhu P, Guo Z, Baba T, et al. (1994). Expression of modified human cytochrome P450 1A2 in Escherichia coli: stabilization, purification, spectral characterization, and catalytic activities of the enzyme. Arch Biochem Biophys 309:168–77.
   PubMed Web of Science ®Google Scholar
• Sasaki S, Itagaki Y, Kurokawa T, et al. (1966). The mass spectra of flavonoids. J Mass Spectr Soc Japan 14:82–92 (in Japanese).
   Google Scholar
• Shimada T. (2006). Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. Drug Metab Pharmacokinet 21:257–76.
   PubMed Web of Science ®Google Scholar
• Shimada T. (2017). Inhibition of carcinogen-activating cytochrome P450 enzymes by xenobiotic chemicals in relation to antimutagenicity and anticarcinogenicity. Toxicol Res 33:79–96.
   PubMed Web of Science ®Google Scholar
• Shimada T, Kim D, Murayama N, et al. (2013). Binding of diverse environmental chemicals with human cytochromes P450 2A13, 2A6, and 1B1 and enzyme inhibition. Chem Res Toxicol 26:517–28.
   PubMed Web of Science ®Google Scholar
• Shimada T, Murayama N, Kakimoto K, et al. (2018). Oxidation of 1-chloropyrene by human CYP1 family and CYP2A subfamily cytochrome P450 enzymes: catalytic roles of two CYP1B1 and five CYP2A13 allelic variants. Xenobiotica 48:565–75.
   PubMed Web of Science ®Google Scholar
• Shimada T, Tanaka K, Takenaka S, et al. (2009). Reverse type I binding spectra of human cytochrome P450 1B1 induced by derivatives of flavonoids, stilbenes, pyrenes, naphthalenes, phenanthrenes, and biphenyls that Inhibit catalytic activity: structure-function relationships. Chem Res Toxicol 22:1325–33.
   PubMed Web of Science ®Google Scholar
• Shimada T, Tanaka K, Takenaka S, et al. (2010). Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives. Chem Res Toxicol 23:1921–35.
   PubMed Web of Science ®Google Scholar
• Si-Ahmed K, Tazerouti F, Badjah-Hadj-Ahmed AY, et al. (2010). Optical isomer separation of flavanones and flavanone glycosides by nano-liquid chromatography using a phenyl-carbamate-propyl-beta-cyclodextrin chiral stationary phase. J Chromatogr A 1217:1175–82.
   PubMed Web of Science ®Google Scholar
• Su T, Bao Z, Zhang QY, et al. (2000). Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res 60:5074–9.
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Brugliera F. (2013). Flower colour and cytochromes P450. Philos Trans R Soc Lond B Biol Sci 368:20120432–14.
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Brugliera F, Kalc G, et al. (2010). Flower color modification by engineering of the flavonoid biosynthetic pathway: practical perspectives. Biosci Biotechnol Biochem 74:1760–9.
   PubMed Web of Science ®Google Scholar
• Uno T, Obe Y, Ogura C, et al. (2013). Metabolism of 7-ethoxycoumarin, safrole, flavanone and hydroxyflavanone by cytochrome P450 2A6 variants. Biopharm Drug Dispos 34:87–97.
   PubMed Web of Science ®Google Scholar
• Uno T, Ogura C, Izumi C, et al. (2015). Point mutation of cytochrome P450 2A6 (a polymorphic variant CYP2A6.25) confers new substrate specificity towards flavonoids. Biopharm Drug Dispos 36:552–63.
   PubMed Web of Science ®Google Scholar
• Walle T. (2007). Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass? Semin Cancer Biol 17:354–62.
   PubMed Web of Science ®Google Scholar
• Walle T, Ta N, Kawamori T, et al. (2007). Cancer chemopreventive properties of orally bioavailable flavonoids-methylated versus unmethylated flavones. Biochem Pharmacol 73:1288–96.
   PubMed Web of Science ®Google Scholar
• Walle UK, Walle T. (2007). Bioavailable flavonoids: cytochrome P450-mediated metabolism of methoxyflavones. Drug Metab Dispos 35:1985–9.
   PubMed Web of Science ®Google Scholar
• Walsky RL, Obach RS. (2007). A comparison of 2-phenyl-2-(1-piperidinyl)propane (ppp), 1,1’,1''-phosphinothioylidynetrisaziridine (thioTEPA), clopidogrel, and ticlopidine as selective inactivators of human cytochrome P450 2B6. Drug Metab Dispos 35:2053–9.
   PubMed Web of Science ®Google Scholar
• Yamazaki H, Nakamura M, Komatsu T, et al. (2002). Roles of NADPH-P450 reductase and apo- and holo-cytochrome b5 on xenobiotic oxidations catalyzed by 12 recombinant human cytochrome P450s expressed in membranes of Escherichia coli. Protein Expr Purif 24:329–37.
   PubMed Web of Science ®Google Scholar
• Yáñez JA, Remsberg CM, Miranda ND, et al. (2008). Pharmacokinetics of selected chiral flavonoids: hesperetin, naringenin and eriodictyol in rats and their content in fruit juices. Biopharm Drug Dispos 29:63–82.
   PubMed Web of Science ®Google Scholar
• Yano JK, Denton TT, Cerny MA, et al. (2006). Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization. J Med Chem 49:6987–7001.
   PubMed Web of Science ®Google Scholar
• Yun CH, Shimada T, Guengerich FP. (1991). Purification and characterization of human liver microsomal cytochrome P-450 2A6. Mol Pharmacol 40:679–85.
   PubMed Web of Science ®Google Scholar
• Zhang S, Yang X, Coburn RA, Morris ME. (2005). Structure activity relationships and quantitative structure activity relationships for the flavonoid-mediated inhibition of breast cancer resistance protein. Biochem Pharmacol 70:627–39.
   PubMed Web of Science ®Google Scholar